From Hopeless to Hopeful: First FDA-Approved Eye Implant Protects Sight in Patients with Rare Blindness
In a groundbreaking development for ophthalmology, the U.S. Food and Drug Administration has approved ENCELTO, a small eye implant designed to treat macular telangiectasia type 2 (MacTel), a rare neurodegenerative retinal disease that gradually erodes central vision. This marks the first FDA-authorized therapy for the condition, offering new hope to thousands affected by the disorder. […]


